Elicera Therapeutics develops new cancer treatment with help of advanced cell lab in Flemingsberg
Uppsala-based Elicera Therapeutics is using the Pre-GMP core facility at Vecura in Flemingsberg as a first step in a study aimed at creating a new treatment for lymph node cancer.
The pre-GMP lab at Campus Flemingsberg makes it possible to use a new method to automate the process of genetically modifying cells for research studies.
“The facility allows us to benefit from a completely closed and automated system that reduces the workload for staff and further ensures quality,” says Magnus Essand, Research Director at Elicera.
In the Pre-GMP lab, the process can be developed and fine-tuned while staff at Vecura receive training in the new methods.
Activating the immune system
The establishment of Elicera Therapeutics was based on research conducted at Uppsala University with the aim of using modified cells – CAR-T cells – to develop new cancer treatments. Cells taken from patients develop the ability to activate the body’s own immune system in the fight against cancer.
The goal of the current study is to identify a treatment for patients with Non-Hodgkin’s lymphoma, a form of lymph node cancer.
“There are currently two approved treatments for the disease, but they don’t work for all patients. We hope that our treatment can also be used by these patients and prevent recurrence,” says Essand, adding: “We hope to develop a curative treatment for these patients.”
Elicera Therapeutics recently received a grant from the European Innovation Council (EIC) to help them grow further. In the future, there are plans to use the company’s findings to develop treatments for patients with brain cancer.
Read more on the Elicera Therapeutics homepage at: elicera.com.
TAKE YOUR IDEA TO THE NEXT LEVEL: Flemingsberg Science Award IDEA 2024 is now open for registration
It’s finally time for the annual competition Flemingsberg Science Award IDEA. The goal is to attract innovators from Flemingsberg, helping them take the step towards realizing their visions while also participating in shaping the businesses of the future. Do you have an idea that can contribute to a better world? Then you should take part in the Flemingsberg Science Award competition.
Welcome to Flemingsberg Pitch Workshop
Together with Venture Cup, one of Sweden's leading platforms for startups and business ideas, Flemingsberg Science Foundation welcomes you to a workshop that will help you create a compelling and engaging pitch to take your startup or idea to the next level. During this highly interactive session Malcolm Larri, coach and pitch expert, will teach you the fundamental building blocks of creating an effective pitch, Venture Cup style. You will also receive feedback on the pitches you create.
Campus day 2024
Campus Day is for all students at Campus Flemingsberg. Come and meet students from Karolinska Institutet, KTH, the Red Cross University College, SMI, and Södertörn University. There will be performances and speeches on stage. Enjoy music, play ping-pong, or take the campus quiz and get a lunch! (Limited availability)
Irma Alert and The Digital Immune System: Winners of the Flemingsberg Science Award STARTUP 2024
Sweden's children and youth are not doing well. Mental health issues, increasing neuropsychiatric disorders, and sociocultural confusion, partly caused by social media, are on the rise. As a result, the level of knowledge among young people is declining, with reading comprehension and mathematics being particularly problematic areas. Irma Alert, the winner of the Flemingsberg Science Award, wants to change this.
Maria Eriksdotter: Dean, Leader and Enthusiast who strengthened the sense of community in Flemingsberg
After her four years as dean, Maria has successfully put KI South and Flemingsberg on the map. Maria is an enthusiast who has driven KI South forward in recent years with great commitment. Now that she is leaving her role as dean of Karolinska Institutet, we at the Flemingsberg Science Foundation reflect on all the progress and achievements she has made.
